Article Dans Une Revue European Journal of Medicinal Chemistry Année : 2013

Design, synthesis and anticancer properties of 5-arylbenzoxepins as conformationally restricted iso combretastatin A-4 analogs

Résumé

A series of novel benzoxepins 6 was designed and prepared as rigid-isoCA-4 analogues according to a convergent strategy using the coupling of N-tosylhydrazones with aryl iodides under palladium catalysis. The most potent compound 6b, having the greatest resemblance to CA-4 and isoCA-4 displayed antiproliferative activity at nanomolar concentrations against various cancer cell lines and inhibited tubulin assembly at a micromolar range. In addition, benzoxepin 6b led to the arrest of HCT116, K562, H1299 and MDA-MB231 cancer cell lines in the G2/M phase of the cell cycle, and strongly induced apoptosis at low concentrations. Docking studies demonstrated that benzoxepin 6b adopt an orientation similar to that of isoCA-4 at the colchicine binding site on -tubulin.

Fichier principal
Vignette du fichier
Eur. J. Med. Chem. Manuscript changement de texte cytotox.pdf (951.92 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)
Licence
Loading...

Dates et versions

hal-02394390 , version 1 (04-12-2019)

Licence

Identifiants

Citer

Evelia Rasolofonjatovo, Jérome Bignon, Olivier Provot, Abdallah Hamze, Jordi Rodrigo, et al.. Design, synthesis and anticancer properties of 5-arylbenzoxepins as conformationally restricted iso combretastatin A-4 analogs. European Journal of Medicinal Chemistry, 2013, 62, pp.28-39. ⟨10.1016/j.ejmech.2012.12.042⟩. ⟨hal-02394390⟩
153 Consultations
335 Téléchargements

Altmetric

Partager

  • More